Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-06-12Clinical Trial Update: PSMA-specific CAR-T Cell Therapy [Phase 1, Phase 2]
A phase 1/2 clinical trial update for a PSMA-specific CAR-T cell therapy is underway for PSMA-positive tumors or tumor tissues.
-
CLINICAL_TRIALS trial_result · 2020-06-11Clinical Trial Update: 68Ga-RM2 Compared to 68Ga-PSMA-617 PET/CT for Prostate Cancer Imaging According to Various Metastatic Risks [Phase 2]
Phase 2 trial comparing 68Ga-RM2 to 68Ga-PSMA-617 PET/CT for imaging prostate cancer across different metastatic risk categories has complet…
-
CLINICAL_TRIALS trial_result · 2020-06-09Clinical Trial Update: RV001V, a RhoC Anticancer Vaccine, Against Metastasis From Solid Tumours [Phase 1, Phase 2]
Phase 1/2 trial of RV001V, a RhoC anticancer vaccine, for metastasis prevention in prostate cancer completed with results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-06-04Clinical Trial Update: A Phase II Study to Evaluate Axumin PET/CT for Risk Stratification for Prostate Cancer [Phase 2]
Phase II study evaluating Axumin PET/CT for risk stratification in prostate cancer has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-06-04Clinical Trial Update: Prostate Boost Irradiation With Stereotactic Body RT (SBRT) [Phase 2]
Phase 2 clinical trial update evaluating prostate boost irradiation using stereotactic body radiotherapy (SBRT) for prostate cancer.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-06-02Clinical Trial Update: FLAME: Investigate the Benefit of a Focal Lesion Ablative Microboost in Prostate Cancer [Phase 3]
Phase 3 trial update evaluating focal lesion ablative microboost in prostate cancer radiotherapy; study completed.
-
CLINICAL_TRIALS trial_result · 2020-06-01Clinical Trial Update: Supportive Therapy in Androgen Deprivation Clinic in Improving Health Outcomes and Managing Side Effects in Patients With Prostate Cancer [Phase 2]
Phase 2 trial evaluating supportive therapy in conjunction with androgen deprivation for prostate adenocarcinoma; study terminated with resu…
-
CLINICAL_TRIALS trial_result · 2020-06-01Clinical Trial Update: Enzalutamide With or Without Abiraterone and Prednisone in Treating Patients With Castration-Resistant Metastatic Prostate Cancer [Phase 3]
Phase 3 trial evaluating enzalutamide with or without abiraterone and prednisone in castration-resistant metastatic prostate cancer; status …
-
CLINICAL_TRIALS trial_result · 2020-05-28Clinical Trial Update: Vaccine Treatment for Hormone Refractory Prostate Cancer [Phase 1, Phase 2]
A phase 1/2 clinical trial update for a vaccine treatment targeting hormone-refractory prostate cancer has completed enrollment and/or data …
-
CLINICAL_TRIALS trial_result · 2020-05-22Clinical Trial Update: A Phase II Study of PX-866 in Patients With Recurrent or Metastatic Castration Resistant Prostate Cancer [Phase 2]
Phase II study of PX-866 in recurrent or metastatic castration-resistant prostate cancer has completed; results posted.
-
CLINICAL_TRIALS trial_result · 2020-05-13Clinical Trial Update: A Safety and Efficacy Study of SHR3680 in Metastatic Castration-Resistant Prostate Cancer Patients [Phase 1, Phase 2]
Clinical trial update for SHR3680 in metastatic castration-resistant prostate cancer across Phase 1 and Phase 2, with unknown status.
-
CLINICAL_TRIALS trial_result · 2020-05-07Clinical Trial Update: Dendritic Cell (DC)-Based Vaccines Loaded With Allogeneic Prostate Cell Lines in Combination With Androgen Ablation in Patients With Prostate Cancer [Phase 2]
Phase 2 trial evaluating dendritic cell-based vaccines loaded with allogeneic prostate cell lines in combination with androgen ablation for …
-
CLINICAL_TRIALS trial_result · 2020-05-05Clinical Trial Update: A Positron Emission Tomography/Computed Tomography (PET/CT) Bone Imaging Study in Patients Receiving Enzalutamide for Castration-Resistant Prostate Cancer (CRPC) [Phase 2]
Phase 2 PET/CT imaging study in patients receiving enzalutamide for castration-resistant prostate cancer with bone metastases has completed …
-
CLINICAL_TRIALS trial_result · 2020-05-04Clinical Trial Update: Safety, Efficacy, and Pharmacokinetic Behavior of Leuprolide Mesylate (LMIS 25 mg) in Subjects With Prostate Cancer [Phase 3]
Phase 3 trial update assessing safety, efficacy, and pharmacokinetics of leuprolide mesylate (LMIS 25 mg) in subjects with prostate cancer; …
-
CLINICAL_TRIALS trial_result · 2020-05-04Clinical Trial Update: Early Changes In Multiparametric MRI In Prostate Cancer [NA]
Clinical trial update on early changes in multiparametric MRI in prostate cancer; results completed and posted.
-
CLINICAL_TRIALS trial_result · 2020-04-28Clinical Trial Update: Randomized Trial of Adjuvant Hormonal Therapy in Surgically Treated Prostate Cancer Patients at High Risk for Recurrence [Phase 3]
Phase 3 randomized trial of adjuvant hormonal therapy after surgery in high-risk prostate cancer; trial status terminated with results poste…
-
CLINICAL_TRIALS trial_result · 2020-04-28Clinical Trial Update: A Study of Effects of Fesoterodine in Men at High Risk for Overactive Bladder/Detrusor Overactivity Post Robotic-Assisted Lap. Prostatectomy [Phase 4]
Phase 4 trial evaluating the effects of fesoterodine in men at high risk for overactive bladder/detrusor overactivity after robotic-assisted…
-
CLINICAL_TRIALS trial_result · 2020-04-08Clinical Trial Update: Deep Versus Moderate Neuromuscular Blockade During Laparoscopic Surgery [Phase 4]
Phase 4 trial comparing deep versus moderate neuromuscular blockade during laparoscopic surgery; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2020-04-07Clinical Trial Update: North Carolina Prostate Cancer Comparative Effectiveness & Survivorship Study (NC ProCESS)
Clinical trial update for the NC ProCESS study in prostate cancer; completed with results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-04-06Clinical Trial Update: ZD 1839 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy [Phase 2]
Phase 2 trial update for ZD 1839 in hormone-refractory prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2020-04-03Clinical Trial Update: Vitamin E, Selenium, and Soy Protein in Preventing Cancer in Patients With High-Grade Prostate Neoplasia [Phase 3]
Phase 3 trial evaluating vitamin E, selenium, and soy protein for prevention in men with high-grade prostate neoplasia has completed.
-
CLINICAL_TRIALS trial_result · 2020-04-03Clinical Trial Update: Hormone Therapy With or Without Surgery or Radiation Therapy in Treating Patients With Prostate Cancer [Phase 3]
Phase 3 trial evaluating hormone therapy with or without surgery or radiation in prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2020-04-03Clinical Trial Update: Combination Chemotherapy in Treating Pain in Hormone Refractory Metastatic Prostate Cancer [Phase 3]
Phase 3 trial updating combination chemotherapy for pain in hormone-refractory metastatic prostate cancer; study completed.
-
CLINICAL_TRIALS trial_result · 2020-04-03Clinical Trial Update: Phase II Study of Sipuleucel-T and Indoximod for Patients With Refractory Metastatic Prostate Cancer [Phase 2]
Phase II study evaluating sipuleucel-T with indoximod for refractory metastatic prostate cancer has completed; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-03-30Clinical Trial Update: A Study of Docetaxel + ARN-509 in Castration-Resistant Prostate Cancer [Phase 2]
Phase 2 trial of docetaxel plus ARN-509 in castration-resistant prostate cancer was terminated; results posted.